NDC 0006-4293

ERVEBO

Zaire Ebolavirus (strain Kikwit-95) Envelope Glycoprotein

ERVEBO is a Intramuscular Injection, Solution in the Vaccine category. It is labeled and distributed by Merck Sharp & Dohme Llc. The primary component is Zaire Ebolavirus (strain Kikwit-95) Envelope Glycoprotein.

• Product ID: 0006-4293_11e8268d-630c-4f98-a22e-8f258481f1ea
• NDC: 0006-4293
• Product Type: Vaccine
• Proprietary Name: ERVEBO
• Generic Name: Zaire Ebolavirus (strain Kikwit-95) Envelope Glycoprotein
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2019-12-19
• Marketing Category: BLA /
• Application Number: BLA125690
• Labeler Name: Merck Sharp & Dohme LLC
• Substance Name: ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN
• Active Ingredient Strength: 72000000 [PFU]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0006-4293-02

10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4293-02) > 1 mL in 1 VIAL, SINGLE-DOSE (0006-4293-01)

• Marketing Start Date: 2019-12-19
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details